Spots Global Cancer Trial Database for tetanus
Every month we try and update this database with for tetanus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma | NCT03927222 | Glioblastoma | Human CMV pp65-... Temozolomide Tetanus-Diphthe... GM-CSF 111-Indium-labe... | 18 Years - | Duke University | |
| Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma | NCT03927222 | Glioblastoma | Human CMV pp65-... Temozolomide Tetanus-Diphthe... GM-CSF 111-Indium-labe... | 18 Years - | Duke University | |
| Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance | NCT06070961 | Follicular Lymp... | Cellular immuni... Humoral immunit... Cellular immuni... Humoral immunit... Diphtheria toxi... Tetanus toxoid-... T-cell populati... | 18 Years - | Fondazione Italiana Linfomi - ETS | |
| Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) | NCT00337428 | Neoplasms, Glan... Diphtheria Tetanus Whooping Cough Poliomyelitis | Comparator: Qua... Comparator: Qua... Comparator: REP... Comparator: REP... | 11 Years - 17 Years | Merck Sharp & Dohme LLC | |
| Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR | NCT01611298 | Acute Lymphobla... Acute Myelogeno... Chronic Myeloge... Myelodysplastic... Hodgkin Lymphom... Non-Hodgkin Lym... | Tetanus | 3 Years - 70 Years | Baylor College of Medicine | |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents | NCT00518180 | Meningococcal M... Human Papilloma... Pertussis Tetanus | Novartis Mening... Tdap Vaccine Novartis Mening... | 11 Years - 18 Years | Novartis | |
| Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR | NCT01611298 | Acute Lymphobla... Acute Myelogeno... Chronic Myeloge... Myelodysplastic... Hodgkin Lymphom... Non-Hodgkin Lym... | Tetanus | 3 Years - 70 Years | Baylor College of Medicine | |
| Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) | NCT00325130 | Neoplasms, Glan... Diphtheria Tetanus Whooping Cough Meningitis | Comparator: Qua... Comparator: Men... Comparator: Ada... Comparator: Men... Comparator: Ada... | 11 Years - 17 Years | Merck Sharp & Dohme LLC | |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents | NCT00518180 | Meningococcal M... Human Papilloma... Pertussis Tetanus | Novartis Mening... Tdap Vaccine Novartis Mening... | 11 Years - 18 Years | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
